HR 6407, the RCORP Authorization Act, authorizes $165 million annually (2026-2030) to fund the Rural Communities Opioid Response Program. This program provides grants to states, tribes, rural health offices, and other eligible entities to expand prevention, treatment, and recovery services for opioid and substance use disorders in rural areas. Funds can support planning, evidence-based service models, and coordination with local communities but cannot be used for real property acquisition. The bill directly affects rural communities facing opioid crises and the organizations delivering care through these grants.
This bill would amend the Anti-Terrorism Act of 1987 to designate the Muslim Brotherhood as a terrorist organization and prohibit its operations within the United States. It would require the President to designate the Muslim Brotherhood as a foreign terrorist organization under immigration law and impose new visa restrictions, including immediate revocation of current visas, for individuals identified as members. The bill mandates annual reports from the Secretary of State identifying Muslim Brotherhood branches worldwide and determining which should be designated as terrorist organizations under existing laws. These provisions would directly affect Muslim Brotherhood members, branches, and affiliated organizations seeking entry to or operating within the United States.
S 3302, the Mikaela Naylon Give Kids a Chance Act of 2025, requires drug manufacturers developing cancer treatments to conduct pediatric-focused research for certain drugs targeting pediatric cancer mechanisms. It amends FDA drug approval processes to mandate molecularly targeted pediatric cancer investigations for drugs with new active ingredients or specific approved combinations, ensuring studies address dosing, safety, and efficacy for children. The bill also extends priority review vouchers (which expedite FDA reviews) for rare pediatric disease treatments until 2030 and mandates GAO studies to evaluate how effectively these incentives spur new pediatric cancer drug development. These changes apply to new drug applications submitted three years after the law's enactment, with reports due to Congress at 6, 8, and 10 years.
This bill requires the Veterans Health Administration to expand its existing informed consent directive (currently covering long-term opioid therapy) to include written consent for five additional medication categories: antipsychotics, stimulants, antidepressants, anxiolytics, and narcotics. It directly affects Veterans receiving VA care for these specific medications, mandating that providers obtain written informed consent before prescribing them. The key mechanism is updating VA Directive 1005 to explicitly apply to these new medication types, ensuring consistent consent processes across VA treatment. This change applies only to VA healthcare settings, not to civilian medical practices.
HCONRES 58 is a symbolic congressional resolution denouncing socialism in all its forms. It does not create new laws or affect any policies, as it is a non-binding statement of opinion. The resolution cites historical events and quotes from Founding Fathers to argue that socialism leads to authoritarianism and economic harm, referencing examples like the Soviet Union and Venezuela. It formally "denounces" socialism and opposes implementing socialist policies in the U.S., but has no legal effect on citizens or government actions. This is a procedural resolution, not a policy measure.
This bill allows workers aged 50 or older to directly roll over employer retirement contributions (from 401(k) plans) into an individual retirement annuity without triggering immediate taxes or penalties. It requires retirement plan administrators to provide clear, plain-language written explanations about rollover rules, including a 30-day review period, tax implications (like the 10% early withdrawal penalty), and what types of distributions cannot be rolled over (such as required minimum distributions). The rules apply to taxable years starting after December 31, 2025, and aim to simplify the process for older workers changing jobs or managing retirement funds. It directly affects workers aged 50+ and retirement plan administrators who must comply with the new disclosure standards.
This bill authorizes Congress to award two gold medals in honor of Charlie Kirk, a conservative activist and founder of Turning Point USA, who was tragically killed in 2025. One medal will go to his family, and the other will be displayed at the Smithsonian Institution to preserve his legacy. The bill does not create new policy or affect any laws - it is purely commemorative, following standard procedures for Congressional Gold Medals. It includes provisions for striking the medals and selling bronze duplicates to cover costs, but contains no substantive legislative changes.
S 3267, the ASAP Act, would require Medicare to cover early detection screening tests for Alzheimer's disease and related dementias starting January 1, 2028. The bill defines these tests as FDA-cleared or approved blood, genomic, or imaging-based screenings for pre-symptomatic or early-stage detection. It directly affects Medicare beneficiaries aged 65+ who may be at risk for Alzheimer's, ensuring coverage for these specific tests once approved. The key provision adds these screenings to Medicare's payment system under Section 1833(h)(1)(A) of the Social Security Act.
The SIMSA Act of 2025 creates a new Schedule A for controlled substances under federal drug law. It defines Schedule A substances as those imported into the U.S. with chemical structures substantially similar to existing Schedule I-V substances and having similar effects on the central nervous system. The bill establishes procedures for the Attorney General to temporarily schedule substances for up to 5 years (with possible 180-day extensions), requiring consultation with the Secretary of Health and Human Services before permanent scheduling. It increases penalties for violations involving Schedule A substances, including prison terms up to 30 years for repeat offenses and higher fines, and requires specific labeling with IUPAC nomenclature for these substances.
This bill extends and expands the Work Opportunity Tax Credit (WOTC), which helps employers hire from targeted groups like veterans, long-term welfare recipients, and individuals in high-unemployment areas. It extends the program through 2030 (from 2025), increases the credit rate to 50% for certain new hires (up from 40%), adds automatic annual inflation adjustments to key dollar amounts, and expands eligibility to include military spouses and people receiving SNAP benefits without an age limit. Employers hiring from these groups will see higher tax credits for qualifying wages, with new rules specifically for agricultural workers, summer youth employees, and veterans. The changes apply to workers hired after December 2025.
This bill would expand Medicare Part B coverage to include medical nutrition therapy for beneficiaries with a wider range of chronic conditions beyond current limits (diabetes and kidney disease). It specifically adds conditions like obesity, hypertension, eating disorders, cancer, gastrointestinal diseases, and HIV to the list of covered illnesses, allowing coverage for prevention, management, or treatment. The bill also allows more healthcare providers - including dietitians, nurse practitioners, and clinical psychologists - to deliver these services. This change would directly affect millions of Medicare beneficiaries managing these conditions who previously lacked coverage for medically necessary nutrition therapy.
The Kidney Care Access Protection Act (HR 6214) improves access to innovative kidney treatments for Medicare beneficiaries with end-stage renal disease. It extends transitional payment adjustments for new renal dialysis drugs and devices for at least three years, then establishes permanent payment adjustments based on actual utilization and costs. The bill also expands Medicare's annual wellness benefit to include kidney disease screening and increases access to kidney disease education services through renal dialysis facilities. These changes apply to Medicare beneficiaries, renal dialysis facilities, and healthcare providers, with key provisions effective January 1, 2026.
